Home / Resource Library / Propensity-matched study of liposomal doxorubicin vs. doxorubicin in first-line DLBCL treatment: efficacy and safety

Propensity-matched study of liposomal doxorubicin vs. doxorubicin in first-line DLBCL treatment: efficacy and safety

Matched study compared liposomal doxorubicin with doxorubicin in treatment of DLBCL.